Weight loss drug could reduce heart attack risk by 20%, study findsA weight loss injection with semaglutide could reduce the risk of heart attacks, strokes, or death due to cardiovascular disease by 20%.
Why Heart Disease Research Still Favors MenWomen are more likely to die from heart attacks due to medical system neglect.Clinical trials for medications often exclude women, leading to gaps in identifying effective treatments.